Evidence map›Paper›PMID 42410177›Full record

ArticleBone marrow transplantation2026

Epigenetic priming with azacitidine-BEAM versus decitabine-BEAM conditioning for autologous transplantation in non-Hodgkin's lymphoma.

Jiajie Tu, Rui Zou, Nana Ping, Qian Zhu, Junhong Li, Xiao Zhang, Danqing Kong, Fan Xia, Lingzi Yu, Peng Zhang and 3 more

Abstract readLetter
PubMed Publisher
In one paragraph

Article in Bone marrow transplantation, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Jiajie Tu *Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Rui Zou *Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Nana Ping *Department of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Qian ZhuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Junhong LiDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Xiao ZhangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Danqing KongDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Fan XiaDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Lingzi YuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Peng ZhangDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China.
Depei WuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. wudepei18@163.com.
Zhengming JinDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. jinzhengming519519@163.com.
Changju QuDepartment of Hematology, The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu Province, China. qcj310@163.com.ORCID http://orcid.org/0000-0003-1803-0008

Funding

Chinese Society of Clinical Oncology (Chinese Society of Clinical Oncology, Beijing Xisike Clinical Oncology Research Foundation) Y-SYBLD2022MS-0028Suzhou Municipal Science and Technology Bureau (Bureau of Science and Technology of Suzhou Municipality) SKYD2023103
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Identifiers

PMID42410177

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.